Sundar Jagannath Selected Research

idecabtagene vicleucel

12/2021	Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy.
3/2021	Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient Populations.
1/2021	KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma.
1/2019	Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sundar Jagannath Research Topics

Disease

164	Multiple Myeloma 12/2022 - 01/2002
33	Neoplasms (Cancer) 01/2022 - 06/2001
12	Thrombocytopenia (Thrombopenia) 12/2021 - 12/2005
8	Disease Progression 01/2022 - 04/2009
8	Fatigue 12/2021 - 07/2006
8	COVID-19 10/2021 - 01/2020
8	Peripheral Nervous System Diseases (PNS Diseases) 10/2021 - 01/2006
6	Nausea 12/2021 - 07/2006
5	Infections 09/2021 - 03/2003
4	Pain (Aches) 10/2021 - 01/2013
4	Diarrhea 01/2020 - 04/2010
4	Plasmacytoma 12/2019 - 04/2006
4	Anemia 10/2018 - 07/2009
3	Agammaglobulinemia (Hypogammaglobulinemia) 01/2021 - 01/2020
3	Inflammation (Inflammations) 10/2020 - 08/2008
3	Neutropenia 01/2020 - 07/2009
3	Fever (Fevers) 09/2019 - 04/2009
3	Compression Fractures (Compression Fracture) 10/2018 - 06/2007
3	Renal Insufficiency (Renal Failure) 11/2014 - 06/2001
3	Paraproteinemias (Monoclonal Gammopathy) 09/2014 - 04/2007
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2013 - 05/2003
2	Cytokine Release Syndrome 09/2021 - 01/2019
2	Frailty 01/2021 - 01/2020
2	Pneumonia (Pneumonitis) 11/2020 - 09/2019
2	Hypertension (High Blood Pressure) 11/2020 - 06/2020
2	Hypoxia (Hypoxemia) 10/2020 - 05/2020
2	Melanoma (Melanoma, Malignant) 02/2020 - 01/2010
2	Myocarditis (Carditis) 09/2019 - 09/2019
2	Sepsis (Septicemia) 09/2019 - 09/2019
2	Heart Failure 09/2019 - 11/2013
2	Metabolic Bone Diseases (Osteopenia) 10/2018 - 06/2007
2	Pancytopenia 10/2018 - 01/2002
2	Hemolysis 01/2018 - 01/2002
2	Testicular Neoplasms (Testicular Cancer) 01/2017 - 01/2010
2	Lymphoma (Lymphomas) 01/2016 - 01/2007
2	Plasma Cell Leukemia 12/2015 - 08/2013
2	Plasma Cell Neoplasms 10/2013 - 10/2012

Drug/Important Bio-Agent (IBA)

47	Bortezomib (Velcade)FDA Link 01/2022 - 06/2003
40	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 03/2003
25	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2006
21	Proteasome InhibitorsIBA 06/2022 - 03/2005
19	selinexorIBA 01/2022 - 01/2018
16	carfilzomibIBA 01/2021 - 06/2011
15	Pharmaceutical PreparationsIBA 12/2022 - 06/2001
13	Monoclonal AntibodiesIBA 01/2022 - 07/2008
10	Chimeric Antigen ReceptorsIBA 06/2022 - 01/2019
9	Thalidomide (Thalomid)FDA Link 01/2013 - 07/2004
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2001
7	pomalidomideIBA 11/2021 - 03/2014
6	B-Cell Maturation AntigenIBA 06/2022 - 01/2019
6	Immunomodulating AgentsIBA 11/2021 - 08/2007
6	AntigensIBA 02/2020 - 07/2006
5	daratumumabIBA 01/2021 - 01/2018
5	CreatinineIBA 12/2019 - 06/2001
4	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022 - 01/2019
4	idecabtagene vicleucelIBA 12/2021 - 01/2019
4	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 10/2012
4	Melphalan (Alkeran)FDA LinkGeneric 11/2020 - 05/2006
4	Biomarkers (Surrogate Marker)IBA 10/2020 - 11/2014
4	Pamidronate (Aredia)FDA LinkGeneric 10/2018 - 06/2001
4	elotuzumabIBA 01/2018 - 06/2012
4	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017 - 09/2010
4	Vorinostat FDA Link 01/2016 - 04/2010
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 02/2010
3	Exportin 1 ProteinIBA 01/2021 - 01/2018
3	Immunoglobulin G (IgG)IBA 11/2020 - 03/2016
3	Interleukin-6 (Interleukin 6)IBA 10/2020 - 05/2013
3	CytokinesIBA 10/2020 - 01/2019
3	Diphosphonates (Bisphosphonates)IBA 01/2018 - 06/2001
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2017 - 09/2010
3	LigandsIBA 09/2015 - 08/2008
2	indatuximab ravtansineIBA 11/2021 - 01/2019
2	Immunoconjugates (Immunoconjugate)IBA 11/2021 - 01/2019
2	Interleukin-8 (Interleukin 8)IBA 10/2020 - 05/2020
2	Oncogene Proteins (Oncogene Protein)IBA 07/2020 - 01/2018
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 07/2020 - 01/2018
2	Ferritins (Ferritin)IBA 06/2020 - 01/2020
2	fibrin fragment D (D-dimer)IBA 06/2020 - 01/2020
2	pembrolizumabIBA 09/2019 - 09/2019
2	Zoledronic Acid (Zometa)FDA Link 10/2018 - 06/2007
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 07/2008
2	Hemoglobins (Hemoglobin)IBA 01/2018 - 07/2013
2	IPH-2101IBA 09/2015 - 11/2012
2	SteroidsIBA 09/2015 - 06/2007
2	PanobinostatIBA 06/2015 - 07/2013
2	Biological ProductsIBA 12/2014 - 07/2004
2	Immunoglobulin A (IgA)IBA 10/2013 - 01/2013
2	siltuximabIBA 07/2013 - 05/2013
2	tanespimycin (17AAG)IBA 12/2011 - 08/2010

Therapy/Procedure

81	Therapeutics 12/2022 - 06/2001
9	Stem Cell Transplantation 01/2022 - 07/2004
7	Transplantation 01/2022 - 07/2008
6	Drug Therapy (Chemotherapy) 01/2022 - 06/2003
5	Immunotherapy 01/2020 - 01/2016
3	Radiotherapy 01/2022 - 01/2013
3	Drug Tapering 07/2009 - 11/2002
2	Artificial Respiration (Mechanical Ventilation) 11/2020 - 06/2020
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2020 - 01/2018
2	Cell Transplantation 01/2020 - 12/2015
2	Hematopoietic Stem Cell Transplantation 02/2016 - 09/2006